IL6 and schizophrenia: Beneficial effects of immunomodulatory therapy in schizophrenia have been already shown and the use of tissue-specific inhibitors of IL-6 or other IL-6-targeted therapy could possibly be useful in the treatment of schizophrenia and comorbid somatic states.